Clinical Trial Update: An Adaptive Design Trial Of GW274150 In The Treatment Of Acute Migraine [Phase 2]

View source ↗

Summary

A Phase 2 adaptive-design trial of GW274150 for acute migraine has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• GW274150

Snippet

Sponsor: GlaxoSmithKline | Conditions: Migraine Disorders, Migraine | Phase 2 | Status: COMPLETED